This product is a polypeptide complex that has an inhibitory effect on Mycobacterium tuberculosis. The mechanism is not clear yet, but it may be related to the inhibition of bacterial protein synthesis. Bacteria are prone to develop drug resistance when used alone. This product has incomplete cross-resistance with kanamycin and puromycin.

This product is a polypeptide complex that has an inhibitory effect on Mycobacterium tuberculosis. The mechanism is not clear yet, but it may be related to the inhibition of bacterial protein synthesis. Bacteria are prone to develop drug resistance when used alone. This product has incomplete cross-resistance with kanamycin and puromycin.

Adrenal cortex hormone drugs. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects. Its mechanism of action is: 1. Anti-inflammatory effect: It reduces and prevents the tissue's response to inflammation, thereby reducing the manifestations of inflammation. It can inhibit the accumulation of inflammatory cells, including macrophages and leukocytes, at the site of inflammation, and inhibit phagocytosis, the release of lysosomal enzymes, and the synthesis and release of inflammatory chemical mediators. 2. Immunosuppressive effect: It includes preventing or inhibiting cell-mediated immune responses, delayed allergic reactions, reducing the number of T lymphocytes, monocytes, and eosinophils, reducing the ability of immunoglobulins to bind to cell surface receptors, and inhibiting the synthesis and release of interleukins, thereby reducing the transformation of T lymphocytes into lymphoblasts.